Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Cancer Metastatic × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 464 Carcinoma, Non-Small-Cell Lung 390 Ovarian Neoplasms 273 Lung Neoplasms 161 Neoplasms 126 Fallopian Tube Neoplasms 122 Esophageal Neoplasms 108 Stomach Neoplasms 103 Carcinoma, Ovarian Epithelial 100 Neoplasm Metastasis 99 Triple Negative Breast Neoplasms 94 Endometrial Neoplasms 79 Squamous Cell Carcinoma of Head and Neck 74 Head and Neck Neoplasms 66 Esophageal Squamous Cell Carcinoma 64 Uterine Cervical Neoplasms 60 Recurrence 43 Parkinson Disease 4, Autosomal Dominant Lewy Body 38 Urinary Bladder Neoplasms 37 Adenocarcinoma of Lung 36 Adenocarcinoma Of Esophagus 33 Melanoma 32 Carcinoma 32 Small Cell Lung Carcinoma 28 Prostatic Neoplasms 28 Pancreatic Neoplasms 27 Carcinoma, Squamous Cell 27 Breast Neoplasms, Male 26 Unspecified Adult Solid Tumor, Protocol Specific 25 Colorectal Neoplasms 24

Interventions

folfirinox 2 Oxaliplatin 2 Irinotecan 2 Gemcitabine 2 toripalimab 1 sintilimab 1 devimistat 1 chloroquine diphosphate 1 balstilimab 1 Taxes 1 Paclitaxel 1 Leucovorin 1 Injections 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1 Chloroquine 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06752811 2026-02-10

pompom

Shanghai Yizhong Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡